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Summary
Endoluminal brachytherapy for lung cancer ensures the delivery of a maximal therapeutic
radiation dose to the tumor with a minimal effect on normal surrounding tissues.
We report on a 62-year-old man, who acutely developed LBBB and heart failure
48 hours after the second course of combined endoluminal and external beam radiation
therapy. After administration of angiotensin converting enzyme inhibitors, diuretics, and
anti-inﬂammatory drugs, electrocardiographic changes resolved and patient completely
recovered. Radiotherapy was reintroduced after ten days.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
One of the main concerns about mediastinal radiotherapy is
the occurrence of cardiovascular side effects, the so-called
radiation-induced heart disease (RIHD).1–3 The conduction
system disease may consist of bundle branch block, and ﬁrst
or higher degree atrioventricular blocks.2,4 To the best of our
knowledge, this is the ﬁrst report of left bundle branch block
(LBBB) and heart failure during endobronchial brachytherapy
for lung cancer, which resolved completely after therapy.
Case report
A 62-year-old man, smoker, has been admitted for mild
dyspnea and dry cough with centrally localized tumour-like
shadow and complete atelectasis of the left lung on chest
X-ray. He had a history of chronic obstructive pulmonary
disease and arterial hypertension. On physical examination,
he was afebrile with signs of cyanosis, decreased breath
sounds and inspiratory rales over the left base. His blood
pressure was 170/100mmHg, heart rate 100 beats/min,
and respiratory rate 22 breaths/min. Pulmonary function
test showed obstructive pattern (forced expiratory volume
in 1st second 1390ml – 46% of predicted, vital capacity
2930ml – 73%). Laboratory analysis, including biochemistry
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and complete blood count was within normal range. Arterial
blood gas analyses showed hypoxemia (PaO2: 7.8 kPa,
SaO2 90%). Electrocardiogram (ECG) showed sinus rhythm
with left ventricular hypertrophy (Fig. 1). Computed
tomography (CT) conﬁrmed central tumor-like mass and
complete atelectasis of the left lung. Bronchoscopy revealed
the left main bronchus tumour, and histological examination
conﬁrmed squamous cell carcinoma. Surgical treatment
Fig. 1. ECG before radiation therapy shows sinus rhythm with left
ventricle hypertrophy.
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Fig. 2. ECG performed during radiation therapy detected left bundle
branch block.
was not feasible due to severely impaired lung function
and consequent respiratory failure thus endobronchial and
external beam radiation therapy were scheduled. Four
sessions of endoluminal radiation therapy were scheduled
at weekly intervals (7Gy per session over a length of 7 cm,
measured at 1 cm from the centre of the source). During
ﬁrst session, the source was placed into left main bronchus
(completely obstructed with malignant tumor) at a distance
of about 1.5 cm from the tracheal carina, and procedure was
uneventful. At second session, 30% regression was observed
and clinical and ECG ﬁndings prior to radiotherapy were
unchanged compared to those on admission. Catheter was
placed over a length of 8 cm measured at 1 cm from the
center of the source and 7Gy dose was used.
Within 48 hours after the second session, the patient
experienced sharp chest pain associated with blood pressure
increase to 220/120mmHg. ECG showed complete LBBB
(Fig. 2) and acute coronary syndrome was suspected. After
intravenous nitroglycerin, blood pressure normalized but
low intensity chest pain persisted. The values of myocardial
necrosis markers (creatine kinase, MB fraction creatine
kinase, lactate dehydrogenase) were within normal limits.
At echocardiography, heart chambers were not enlarged,
systolic function and left ventricular ejection fraction were
normal, but diastolic ﬁlling was impaired and suggestive
for diastolic dysfunction. Minimal pericardial effusion up to
8mm in diastole without any ﬁlling abnormalities or collapse
was present. We suspected radiation induced myopericardi-
tis with left bundle branch block. The non-steroid anti-
inﬂammatory drug diclofenac sodium (75mg intramuscular
injections three times daily) and oral methylprednisolon
(20mg daily) was introduced. On the third day, clinical signs
suggestive for heart failure emerged: orthopnoa, inspiratory
crackles, elevated jugular venous pressure, and third heart
sound. Chest X-ray showed enlarged heart, and repeated
analysis of myocardial necrosis markers was normal. ECG
showed sinus rhythm, heart rate 60 beats/min, and normal
QRS complex. We performed radionuclide ventriculography
with 99m Tc which demonstrated lower 1/3 left ventricle
ejection fraction (EF1/3: 21%), impaired diastolic function
and paradoxical septal movement. The patient received
furosemide 40mg, spironolactone 25mg, captopril 12.5mg
Fig. 3. ECG after radiation therapy showed left ventricle
hypertrophy and nonspeciﬁc T abnormality.
bid, digitalis, and oxygen. Treatment was continued and
patient gradually improved but intermittent LBBB was
recorded. After complete resolution, radiation therapy was
reintroduced with additional two sessions of endobronchial
(7Gy) and 10 sessions of external beam radiation with
a satisfactory response. ECG signs of LBBB completely
recovered within two months (Fig. 3).
Discussion
Brachytherapy ensures the delivery of a maximal ther-
apeutic dose to the tumor with a minimal effect on
normal surrounding tissues.5 During thoracic radiotherapy, a
portion of the heart is frequently damadged during primary
treatment, and RIHD is considered to be a treatment
related complication. It may present as acute and chronic
pericarditis, coronary artery disease, valvular dysfunction,
conduction abnormalities, and cardiomyopathy.6,7 Conduc-
tion abnormalities usually have late onset, especially in
patients who had not received subcarinal blocking. Related
ECG abnormalities have been described in 46–48% of the
patients.
Transient complete heart block following radiation
treatment was ﬁrst described by Kremer and Laplace
in 1936, and atrioventricular block requiring pace-maker
implantation following radiotherapy remains rare.4 The
mean interval between treatment and the appearance of
heart block is about 12 years (range 10–15 years).1–4 There is
a wide spectrum of abnormalities that includes the sick sinus
syndrome, all forms of atrio-ventricular block, and bundle
branch block.7–9 The latency period following radiation was
the most important risk factor for the development of
valvular and conduction disease abnormalities and it was
not age-dependent.10
LBBB usually develops in patients with coronary artery
disease, particularly during acute coronary syndrome, which
was excluded in our patient. In our patient, LBBB developed
during endoscopic brachytherapy, and likely contributed to
clinical heart failure. During the procedure, catheter has
been placed near the His’s bundle thus direct radiation
damage to the heart conducting system is most likely
the mechanism of LBBB. Additionally, myocardial diastolic
function was also affected, which resolved after treatment
with ACE inhibitor, diuretic, and digitalis. Complete
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resolution of LBBB and patient clinical presentation followed
a course of non steroid anti-inﬂammatory drugs.
Conclusions
To our knowledge, this report presents the ﬁrst case of
LBBB during brachytherapy for lung cancer. This paper
aims to highlight this serious but treatable transduction
complication. Clinicians should be aware of this com-
plication and adequate diagnostic assessment, including
cardiac imaging and laboratory analysis, is warranted,
before speciﬁc therapeutic decisions are taken.
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